Barclays’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Buy |
684,599
+524,553
| +328% | +$8.92M | ﹤0.01% | 1074 |
|
|
2025
Q1 | $3.13M | Sell |
160,046
-117,973
| -42% | -$2.3M | ﹤0.01% | 1731 |
|
|
2024
Q4 | $6.9M | Buy |
278,019
+94,805
| +52% | +$2.35M | ﹤0.01% | 1362 |
|
|
2024
Q3 | $4.49M | Buy |
183,214
+101,387
| +124% | +$2.48M | ﹤0.01% | 1604 |
|
|
2024
Q2 | $1.92M | Sell |
81,827
-4,849
| -6% | -$114K | ﹤0.01% | 1738 |
|
|
2024
Q1 | $2.86M | Sell |
86,676
-161,708
| -65% | -$5.34M | ﹤0.01% | 1696 |
|
|
2023
Q4 | $6.76M | Buy |
248,384
+50,737
| +26% | +$1.38M | ﹤0.01% | 1293 |
|
|
2023
Q3 | $4.75M | Buy |
197,647
+53,115
| +37% | +$1.28M | ﹤0.01% | 1159 |
|
|
2023
Q2 | $4.62M | Buy |
144,532
+28,903
| +25% | +$923K | ﹤0.01% | 1271 |
|
|
2023
Q1 | $3.54M | Sell |
115,629
-5,990
| -5% | -$183K | ﹤0.01% | 1279 |
|
|
2022
Q4 | $4.76M | Buy |
121,619
+12,883
| +12% | +$504K | ﹤0.01% | 1143 |
|
|
2022
Q3 | $5.18M | Buy |
108,736
+78,267
| +257% | +$3.73M | 0.01% | 1078 |
|
|
2022
Q2 | $1.18M | Buy |
30,469
+15,444
| +103% | +$598K | ﹤0.01% | 1938 |
|
|
2022
Q1 | $859K | Buy |
+15,025
| New | +$859K | ﹤0.01% | 2431 |
|